Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of alzheimer's disease (AβPP/PS1)

Journal of Alzheimer's Disease

Volumn 30, Issue 2, 2012, Pages 337-353

  Esteras, Noemí ^a   Alquézar, Carolina ^a,f   Bartolomé, Fernando ^a   Antequera, Desiree ^b   Barrios, Laura ^c   Carro, Eva ^b,e   Cerdán, Sebastián ^d   Martín Requero, Ángeles ^a,f  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c CSIC Centro Tecnico de Informatica CTI   (Spain)

^d INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^f CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

ADC maps; Alzheimer's disease; MRI; MRS; MT maps; transgenic mice; ventricle enlargement

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CHOLINE; CREATINE; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN SLICE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIFFUSION WEIGHTED IMAGING; HEART LEFT VENTRICLE HYPERTROPHY; HIPPOCAMPUS; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SUBCORTEX; WILD TYPE;

EID: 84861521842     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-111967     Document Type: Article

References (71)

1. Jellinger KA (2006) Alzheimer 100-highlights in the history of Alzheimer research. J Neural Transm 113, 1603-1623.
2. Goedert M, Spillantini MG (2006) A century of Alzheimer's disease. Science 314, 777-781. (Pubitemid 44706636)
3. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, Dubas F, Frebourg T, Campion D (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38, 24-26. (Pubitemid 43011878)
4. Higgins GA, Jacobsen H (2003) Transgenic mouse models of Alzheimer's disease: Phenotype and application. Behav Pharmacol 14, 419-438. (Pubitemid 37176800)
5. McGowan E, Eriksen J, Hutton M (2006) A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet 22, 281-289.
6. Wilcock DM (2010) The usefulness and challenges of trans-genic mouse models in the study of Alzheimer's disease. CNS Neurol Disord Drug Targets 9, 386-394.
7. O'Brein JT, Desmond P, Ames D, Schweitzer I, Chiu E, Tress B (1997) Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment. Psychol Med 27, 1267-1275. (Pubitemid 27494092)
8. Petrella JR, Coleman RE, Doraiswamy PM (2003) Neu-roimaging and early diagnosis of Alzheimer disease: A look to the future. Radiology 226, 315-336. (Pubitemid 36313415)
9. Mosconi L, Brys M, Glodzik-Sobanska L, DeSanti S, Rusinek H, de Leon MJ (2007) Early detection of Alzheimer's disease using neuroimaging. Exp Gerontol 42, 129-138. (Pubitemid 44937821)
10. Thompson PM, Hayashi KM, Dutton RA, Chiang MC, Leow AD, Sowell ER, De Zubicaray G, Becker JT, Lopez OL, Aizenstein HJ, Toga AW (2007) Tracking Alzheimer's disease. Ann N Y Acad Sci 1097, 183-214. (Pubitemid 47084892)
11. Busatto GF, Diniz BS, Zanetti MV (2008) Voxel-based mor-phometry in Alzheimer's disease. Expert Rev Neurother 8, 1691-1702.
12. Leow AD, Yanovsky I, Parikshak N, Hua X, Lee S, Toga AW, Jack CR Jr, Bernstein MA, Britson PJ, Gunter JL, Ward CP, Borowski B, Shaw LM, Trojanowski JQ, Fleisher AS, Harvey D, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM (2009) Alzheimer's disease neuroimaging initiative: A one-year follow up study using tensor-based morphome-try correlating degenerative rates, biomarkers and cognition. Neuroimage 45, 645-655.
13. Budinger TF, Benaron DA, Koretsky AP (1999) Imaging transgenic animals. Annu Rev Biomed Eng 1, 611-648. (Pubitemid 129740025)
14. Delatour B, Guegan M, Volk A, Dhenain M (2006) In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice. Neurobiol Aging 27, 835-847.
15. Sharief AA, Badea A, Dale AM, Johnson GA (2008) Automated segmentation of the actively stained mouse brain using multi-spectral MR microscopy. Neuroimage 39, 136-145. (Pubitemid 350102215)
16. Strome EM, Doudet DJ (2007) Animal models of neurode-generative disease: Insights from in vivo imaging studies. Mol Imaging Biol 9, 186-195. (Pubitemid 47028734)
17. Choi JK, Jenkins BG, Carreras I, Kaymakcalan S, Cormier K, Kowall NW, Dedeoglu A (2010) Anti-inflammatory treatment in AD mice protects against neuronal pathology. Exp Neurol 223, 377-384.
18. Van Broeck B, Vanhoutte G, Pirici D, Van Dam D, Wils H, Cuijt I, Vennekens K, Zabielski M, Michalik A, Theuns J, De Deyn PP, Van der Linden A, Van Broeckhoven C, Kumar-Singh S (2008) Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Neurobiol Aging 29, 241-252.
19. Pereira AC, Huddleston DE, Brickman AM, Sosunov AA, Hen R, McKhann GM, Sloan R, Gage FH, Brown TR, Small SA (2007) An in vivo correlate of exercise-induced neuroge-nesis in the adult dentate gyrus. Proc Natl Acad Sci USA 104, 5638-5643. (Pubitemid 47175733)
20. Antequera D, Vargas T, Ugalde C, Spuch C, Molina JA, Ferrer I, Bermejo-Pareja F, Carro E (2009) Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease. Neurobiol Dis 36, 42-50.
21. Kurt MA, Davies DC, Kidd M, Duff K, Rolph SC, Jennings KH, Howlett DR (2001) Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Exp Neurol 171, 59-71. (Pubitemid 32848445)
22. Yang DS, Kumar A, Stavrides P, Peterson J, Peterhoff CM, Pawlik M, Levy E, Cataldo AM, Nixon RA (2008) Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease. Am J Pathol 173, 665-681.
23. Spuch C, Antequera D, Portero A, Orive G, Hernandez RM, Molina JA, Bermejo-Pareja F, Pedraz JL, Carro E (2010) The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease. Biomaterials 31, 5608-5618.
24. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K (1998) Accelerated Alzheimer-type phe-notype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4, 97-100. (Pubitemid 28133087)
25. Van Putten HP, Bouwhuis MG, Muizelaar JP, Lyeth BG, Berman RF (2005) Diffusion-weighted imagingof edema following traumatic brain injury in rats: Effects of secondary hypoxia. J Neurotrauma 22, 857-872. (Pubitemid 41153871)
26. Franklin K, Paxinos G (1997) The Mouse Brain in Stereotaxic Coordinates, Academic Press, San Diego.
27. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivoproton NMR spectra. Magn Reson Med 30, 672-679. (Pubitemid 23360802)
28. Hosmer DW, Lemeshow S (2001) Applied logistic regression (Wiley Series in probability and statistics), John Wiley, New York.
29. Webster B, Hansen L, Adame A, Crews L, Torrance M, Thal L, Masliah E (2006) Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease. J Neuropathol Exp Neurol 65, 142-151.
30. Bradley KM, Bydder GM, Budge MM, Hajnal JV, White SJ, Ripley BD, Smith AD (2002) Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease. Br J Radiol 75, 506-513. (Pubitemid 34863406)
31. de Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Tsui W, Saint Louis LA, Sobanska L, Brys M, Li Y, Rich K, Rinne J, Rusinek H (2007) Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann N Y Acad Sci 1097, 114-145. (Pubitemid 47084889)
32. Lee JY, Friedman JE, Angel I, Kozak A, Koh JY (2004) The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice. Neurobiol Aging 25, 1315-1321. (Pubitemid 39299169)
33. Wengenack TM, Jack CR Jr, Garwood M, Poduslo JF (2008) MR microimaging of amyloid plaques in Alzheimer's disease transgenic mice. Eur J Nucl Med Mol Imaging 35 (Suppl 1), S82-S88.
34. Yang D, Xie Z, Stephenson D, Morton D, Hicks CD, Brown TM, Sriram R, O'Neill S, Raunig D, Bocan T (2011) Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510). Neuroimage 54, 2652-2658.
35. Lau JC, Lerch JP, Sled JG, Henkelman RM, Evans AC, Bedell BJ (2008) Longitudinal neuroanatomical changes determined by deformation-based morphometry in a mouse model of Alzheimer's disease. Neuroimage 42, 19-27.
36. Marjanska M, Curran GL, Wengenack TM, Henry PG, Bliss RL, Poduslo JF, Jack CR Jr, Ugurbil K, Garwood M (2005) Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci USA 102, 11906-11910. (Pubitemid 41170823)
37. von Kienlin M, Kunnecke B, Metzger F, Steiner G, Richards JG, Ozmen L, Jacobsen H, Loetscher H (2005) Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span. Neurobiol Dis 18, 32-39. (Pubitemid 40092895)
38. Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, Fogarty J, Bartha R (2008) Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain 131, 2443-2454.
39. Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tan-galos EG, Petersen RC (2004) Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62, 591-600. (Pubitemid 38252801)
40. Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, Whitwell JL, Jenkins L, Black RS, Grundman M, Fox NC (2008) Volumetric MRI and cognitive measures in Alzheimer disease: Comparison of markers of progression. J Neurol 255, 567-574.
41. Silbert LC, Quinn JF, Moore MM, Corbridge E, Ball MJ, Murdoch G, Sexton G, Kaye JA (2003) Changes in premorbid brain volume predict Alzheimer's disease pathology. Neurology 61, 487-492. (Pubitemid 37025365)
42. Xie Z, Yang D, Stephenson D, Morton D, Hicks C, Brown T, Bocan T (2010) Characterizing the regional structural difference of the brain between tau transgenic (rTg4510) and wild-type mice using MRI. Med Image Comput Comput Assist Interv 13, 308-315.
43. Chen CC, Tung YY, Chang C (2011) A lifespan MRI evaluation of ventricular enlargement in normal aging mice. Neurobiol Aging 32, 2299-2307.
44. Redwine JM, Kosofsky B, Jacobs RE, Games D, Reilly JF, Morrison JH, Young WG, Bloom FE (2003) Dentate gyrus volumeis reduced before onset of plaque formationinPDAPP mice:Amagnetic resonance microscopy and stereologic analysis. Proc Natl Acad Sci USA 100, 1381-1386. (Pubitemid 36184010)
45. Oberg J, Spenger C, Wang FH, Andersson A, Westman E, Skoglund P, Sunnemark D, Norinder U, Klason T, Wahlund LO, Lindberg M (2008) Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice. Neurobiol Aging 29, 1423-1433. (Pubitemid 351970599)
46. Maheswaran S, Barjat H, Rueckert D, Bate ST, Howlett DR, Tilling L, Smart SC, Pohlmann A, Richardson JC, Hartkens T, Hill DL, Upton N, Hajnal JV, James MF (2009) Longitudinal regional brain volume changes quantified innormal aging and Alzheimer's APP × PS1 mice using MRI. Brain Res 1270, 19-32.
47. Kabani NJ, Sled JG, Chertkow H (2002) Magnetization transfer ratio in mild cognitive impairment and dementia of Alzheimer's type. Neuroimage 15, 604-610. (Pubitemid 34852528)
48. Hanyu H, Asano T, Iwamoto T, Takasaki M, Shindo H, Abe K (2000) Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia. AJNR Am J Neurora-diol 21, 1235-1242. (Pubitemid 30655657)
49. Hanyu H, Asano T, Sakurai H, Takasaki M, Shindo H, Abe K (2001) Magnetization transfer measurements of the hippocampus in the early diagnosis of Alzheimer's disease. J Neurol Sci 188, 79-84. (Pubitemid 32727877)
50. van der Flier WM, van den Heuvel DM, Weverling-Rijnsburger AW, Bollen EL, Westendorp RG, van Buchem MA, Middelkoop HA (2002) Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann Neurol 52, 62-67. (Pubitemid 34693744)
51. van Buchem MA, Tofts PS (2000) Magnetization transfer imaging. Neuroimaging Clin N Am 10, 771-788, ix. (Pubitemid 32391267)
52. Ridha BH, Symms MR, Tozer DJ, Stockton KC, Frost C, Sid-dique MM, Lewis EB, MacManus DG, Boulby PA, Barker GJ, Rossor MN, Fox NC, Tofts PS (2007) Magnetization transfer ratio in Alzheimer disease: Comparison with volumetric measurements. AJNR Am J Neuroradiol 28, 965-970. (Pubitemid 46776084)
53. Gass A, Niendorf T, Hirsch JG (2001) Acute and chronic changes of the apparent diffusion coefficient in neurological disorders-biophysical mechanisms and possible underlying histopathology. J Neurol Sci 186 (Suppl 1), S15-S23.
54. Thiessen JD, Glazner KA, Nafez S, Schellenberg AE, Buist R, Martin M, Albensi BC (2010) Histochemical visualization and diffusion MRI at 7 Tesla in the TgCRND8 transgenic model of Alzheimer's disease. Brain Struct Funct 215, 29-36.
55. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD (1993) Alzheimer disease: Depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 187, 433-437. (Pubitemid 23127850)
56. Moats RA, Ernst T, Shonk TK, Ross BD (1994) Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 32, 110-115. (Pubitemid 24198562)
57. Shonk TK, Moats RA, Gifford P, Michaelis T, Mandigo JC, Izumi J, Ross BD (1995) Probable Alzheimer disease: Diagnosis with proton MR spectroscopy. Radiology 195, 65-72.
58. Ross BD, Bluml S, Cowan R, Danielsen E, Farrow N, Tan J (1998) In vivo MR spectroscopy of human dementia. Neu-roimaging Clin N Am 8, 809-822. (Pubitemid 28532518)
59. Jessen F, Traeber F, Freymann N, Maier W, Schild HH, Heun R, Block W (2005) A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease. Dement Geriatr Cogn Disord 20, 178-183. (Pubitemid 41191635)
60. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai DF, O'Brien PC, Weigand SD, Edland SD, Smith GE, Ivnik RJ, Ferman TJ, Tangalos EG, Jack CR Jr (2004) 1H MR spectroscopyincommon dementias. Neurology 63, 1393-1398.
61. Valenzuela MJ, Sachdev P (2001) Magnetic resonance spec-troscopy in AD. Neurology 56, 592-598.
62. Wang Z, Zhao C, Yu L, Zhou W, Li K (2009) Regional metabolic changesinthe hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease. Acta Radiol 50, 312-319.
63. den Heijer T, Sijens PE, Prins ND, Hofman A, Koudstaal PJ, Oudkerk M, Breteler MM (2006) MR spectroscopy of brain white matter in the prediction of dementia. Neurology 66, 540-544. (Pubitemid 43739884)
64. Kantarci K, Lowe V, Przybelski SA, Senjem ML, Weigand SD, Ivnik RJ, Roberts R, Geda YE, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr (2011) Magnetic resonance spectroscopy, beta-amyloid load, and cognition in a population-based sample of cognitively normal older adults. Neurology 77, 951-958.
65. Donovan MH, Yazdani U, Norris RD, Games D, German DC, Eisch AJ (2006) Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease. J Comp Neurol 495, 70-83. (Pubitemid 43238052)
66. Lopez-Toledano MA, Shelanski ML (2007) Increased neu-rogenesis in young transgenic mice overexpressing human APP (Sw, Ind.). J Alzheimers Dis 12, 229-240. (Pubitemid 350179250)
67. Perez-Gonzalez R, Antequera D, Vargas T, Spuch C, Bolos M, Carro E (2011) Leptin induces proliferation of neuronal progenitors and neuroprotectioninamouse modelofAlzheimer's disease. J Alzheimers Dis 24 (Suppl 2), 17-25.
68. Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC, Greenberg DA (2004) Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci USA 101, 343-347. (Pubitemid 38084252)
69. Wurtman RJ, Blusztajn JK, Maire JC (1985) "Autocanni-balism" of choline-containing membrane phospholipids in the pathogenesis of Alzheimer's disease-A hypothesis. Neurochem Int 7, 369-372. (Pubitemid 15116219)
70. Westman E, Spenger C, Oberg J, Reyer H, Pahnke J, Wahlund LO (2009) In vivo 1H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment. BMC Neurosci 10, 33.
71. Bartha R, Smith M, Rupsingh R, Rylett J, Wells JL, Borrie MJ (2008) High field (1) H MRS of the hippocampus after donepezil treatment in Alzheimer disease. Prog Neuropsy-chopharmacol Biol Psychiatry 32, 786-793. (Pubitemid 351312380)